In this study, we demonstrate that the high expression of SOCS5 promotes SREBP1-mediated de novo lipogenesis and LD production and is one of the driver genes for HCC lipid metabolism reprogramming. This evidence concerns the gene SOCS5 and hepatocellular carcinoma.